4th Quarter - Report

CENTER FOR SCIENCE IN THE PUBLIC INTEREST for CENTER FOR SCIENCE IN THE PUBLIC INTEREST

Firm
Client
Income
—
Expenses
$22,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Food Industry (safety, labeling, etc.) FOO

Zoonotic disease bill, not yet introduced (MEZDA), And Expanded Food Safety Investigation Act, poppy seed bill, infant formula (EFSIA HR 4110 S2782; Stephen Hacala Poppy Seed Safety HR 6512; S 3354); Additives issues generally (trying to get various bills introduced) (no bill number); TRUTH in Labeling Act (S.3512/H.R.6766); Dietary Supplement Reform (no bill no); Mitigation of Emerging Zoonotic Disease Act (no bill no)

LobbyistCovered position, as disclosed
JOSE JENSEN New —
COLIN SCHWARTZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB)

Bills named: H.R. 6766 (118th), S. 3512 (118th), H.R. 6512 (118th), H.R. 4110 (118th)

Budget/Appropriations BUD

VALID Act of 2023; LDT regulation by FDA (docket no: FDA-2023-N-2177); Appropriations, bill no. HR 2369

LobbyistCovered position, as disclosed
COLIN SCHWARTZ —

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2369 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.